share_log

完美醫療:股份發行人的證券變動月報表截至二零二四年三月三十一日

PERFECT MEDICAL: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024

香港交易所 ·  Apr 2 05:26
Summary by Moomoo AI
完美醫療健康管理有限公司(股份代號:01830.HK)於2024年4月2日向香港交易及結算所有限公司提交了最新的證券變動月報表,報告截至2024年3月31日的公司股本變動情況。報告顯示,公司的法定/註冊股本及已發行股份在報告期內均無變動,維持在10,000,000,000股,每股面值0.1港元,總額為1,000,000,000港元。此外,公司的股份期權計劃於本月內無新增變動,結存的股份期權數目為3,768,000,並無因行使期權而發行新股份。公司確認,所有證券的發行均已獲得董事會的正式授權,並符合香港聯合交易所有限公司證券上市規則的相關要求。
完美醫療健康管理有限公司(股份代號:01830.HK)於2024年4月2日向香港交易及結算所有限公司提交了最新的證券變動月報表,報告截至2024年3月31日的公司股本變動情況。報告顯示,公司的法定/註冊股本及已發行股份在報告期內均無變動,維持在10,000,000,000股,每股面值0.1港元,總額為1,000,000,000港元。此外,公司的股份期權計劃於本月內無新增變動,結存的股份期權數目為3,768,000,並無因行使期權而發行新股份。公司確認,所有證券的發行均已獲得董事會的正式授權,並符合香港聯合交易所有限公司證券上市規則的相關要求。
Perfect Healthcare Management Limited (Stock Code: 01830.HK) filed with Hong Kong Trading and Settlement Limited on 2 April 2024 with Hong Kong Trading and Settlement Limited, reporting the changes in the company's share capital as of 31 March 2024. The report shows that the company's regulated/registered share capital and issued shares remained unchanged during the reporting period, at 10,000,000,000 shares with a face value of HK$0.1 per share for a total of HK$1,000,000,000. In addition, the Company's share options plan is unchanged during the month, with 3,768,000 outstanding share options and no new shares will be issued as a result of the exercise of options. The Company confirms that all issuance of securities has been formally authorized by the Board of Directors and complies with the relevant requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.
Perfect Healthcare Management Limited (Stock Code: 01830.HK) filed with Hong Kong Trading and Settlement Limited on 2 April 2024 with Hong Kong Trading and Settlement Limited, reporting the changes in the company's share capital as of 31 March 2024. The report shows that the company's regulated/registered share capital and issued shares remained unchanged during the reporting period, at 10,000,000,000 shares with a face value of HK$0.1 per share for a total of HK$1,000,000,000. In addition, the Company's share options plan is unchanged during the month, with 3,768,000 outstanding share options and no new shares will be issued as a result of the exercise of options. The Company confirms that all issuance of securities has been formally authorized by the Board of Directors and complies with the relevant requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more